{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-149802","form_type":"8-K","ticker":"GLUE","cik":"0001826457","company_name":"Monte Rosa Therapeutics, Inc.","filed_at":"2024-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.443845+00:00","generated_at":"2026-06-01T07:27:54.077860+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Monte Rosa Therapeutics promotes three executives to CSO, CBO/CLO, and COO","bullets":["Sharon Townson, Ph.D., promoted to Chief Scientific Officer; previously CTO.","Phil Nickson, Ph.D., J.D., promoted to Chief Business and Legal Officer; previously General Counsel.","Jennifer Champoux promoted to Chief Operating Officer; previously Chief People and Operations Officer.","All promotions effective immediately as of May 30, 2024.","No departures announced; internal promotions reflect pipeline and platform advancement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-149802","json":"https://secwatch.observer/filing/0001193125-24-149802.json","markdown":"https://secwatch.observer/filing/0001193125-24-149802.md","text":"https://secwatch.observer/filing/0001193125-24-149802.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826457/000119312524149802/0001193125-24-149802-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826457/000119312524149802/d836893d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:27:54.077860+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cb980cf84d","claim":"Jennifer Champoux changed role as Chief Operating Officer at Monte Rosa Therapeutics, Inc..","evidence_excerpt":"On May 28, 2024, the Compensation, Nomination and Corporate Governance Committee of Board of Directors of Monte Rosa Therapeutics, Inc. (the “Company”) promoted Jennifer Champoux, the Company’s Chief People and Operations Officer, to serve as the Company’s Chief Operating Officer, effective as of May 28, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1826457/000119312524149802/0001193125-24-149802-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}